|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Diaz-Garcia CV, Agudo-Lopez A, Perez C,
López-Martín JA, Rodríguez-Peralto JL, de Castro J, Cortijo A,
Martínez-Villanueva M, Iglesias L, García-Carbonero R, et al:
DICER1, DROSHA and miRNAs in patients with non-small cell lung
cancer: Implications for outcomes and histologic classification.
Carcinogenesis. 34:1031–1038. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hariu H, Hirohashi Y, Torigoe T, Asanuma
H, Hariu M, Tamura Y, Aketa K, Nabeta C, Nakanishi K, Kamiguchi K,
et al: Aberrant expression and potency as a cancer immunotherapy
target of inhibitor of apoptosis protein family, Livin/ML-IAP in
lung cancer. Clin Cancer Res. 11:1000–1009. 2005.PubMed/NCBI
|
|
4
|
Li J, Chen P, Li XQ, Bao QL, Dai CH and Ge
LP: Elevated levels of survivin and livin mRNA in bronchial
aspirates as markers to support the diagnosis of lung cancer. Int J
Cancer. 132:1098–1104. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tanabe H, Yagihashi A, Tsuji N, Shijubo Y,
Abe S and Watanabe N: Expression of survivin mRNA and livin mRNA in
non-small-cell lung cancer. Lung Cancer. 46:299–304. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhuang L, Shen LD, Li K, Yang RX, Zhang
QY, Chen Y, Gao CL, Dong C, Bi Q, Tao JN, et al: Inhibition of
livin expression suppresses cell proliferation and enhances
chemosensitivity to cisplatin in human lung adenocarcinoma cells.
Mol Med Rep. 12:547–552. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yuan D, Liu L, Xu H and Gu D: The effects
on cell growth and chemosensitivity by livin RNAi in non-small cell
lung cancer. Mol Cell Biochem. 320:133–140. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sun JG, Liao RX, Zhang SX, Duan YZ, Zhuo
WL, Wang XX, Wang ZX, Li DZ and Chen ZT: Role of inhibitor of
apoptosis protein Livin in radiation resistance in nonsmall cell
lung cancer. Cancer Biother Radiopharm. 26:585–592. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kasof GM and Gomes BC: Livin, a novel
inhibitor of apoptosis protein family member. J Biol Chem.
276:3238–3246. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Crnkovic-Mertens I, Muley T, Meister M,
Hartenstein B, Semzow J, Butz K and Hoppe-Seyler F: The
anti-apoptotic livin gene is an important determinant for the
apoptotic resistance of non-small cell lung cancer cells. Lung
Cancer. 54:135–142. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lin X, Li HR, Lin XF, Yu ME, Tu XW, Hua
ZD, Lin M, Xu NL, Han LL and Chen YS: Silencing of Livin inhibits
tumorigenesis and metastasis via VEGF and MMPs pathway in lung
cancer. Int J Oncol. 47:657–667. 2015.PubMed/NCBI
|
|
12
|
Lau NC, Lim LP, Weinstein EG and Bartel
DP: An abundant class of tiny RNAs with probable regulatory roles
in Caenorhabditis elegans. Science. 294:858–862. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lee RC and Ambros V: An extensive class of
small RNAs in Caenorhabditis elegans. Science. 294:862–864.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kim VN and Nam JW: Genomics of microRNA.
Trends in genetics. TIG. 22:165–173. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Farazi TA, Spitzer JI, Morozov P and
Tuschl T: miRNAs in human cancer. J Pathol. 223:102–115. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Puisségur MP, Mazure NM, Bertero T,
Pradelli L, Grosso S, Robbe-Sermesant K, Maurin T, Lebrigand K,
Cardinaud B, Hofman V, et al: miR-210 is overexpressed in late
stages of lung cancer and mediates mitochondrial alterations
associated with modulation of HIF-1 activity. Cell Death Differ.
18:465–478. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wu S, Zhang G, Li P, Chen S, Zhang F, Li
J, Jiang C, Chen X, Wang Y, Du Y, et al: miR-198 targets SHMT1 to
inhibit cell proliferation and enhance cell apoptosis in lung
adenocarcinoma. Tumour Biol. 37:5193–5202. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Pardo OE, Castellano L, Munro CE, Hu Y,
Mauri F, Krell J, Lara R, Pinho FG, Choudhury T, Frampton AE, et
al: miR-515-5p controls cancer cell migration through MARK4
regulation. EMBO Rep. 17:570–584. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chen YS, Li HR, Lin M, Chen G, Xie BS, Xu
NL and Lin LF: Livin abrogates apoptosis of SPC-A1 cell by
regulating JNKI signaling pathway. Mol Biol Rep. 37:2241–2247.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Dubrez-Daloz L, Dupoux A and Cartier J:
IAPs: More than just inhibitors of apoptosis proteins. Cell Cycle.
7:1036–1046. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sun J, Liao R, Chen Z, Wang Z, Zhang Q and
Hu Y: Study on enhancing sensitivity of SPC-A1 cells to
chemotherapy by Livin isoform-specific gene silencing. Zhongguo Fei
Ai Za Zhi. 10:461–465. 2007.(In Chinese). PubMed/NCBI
|
|
22
|
Yuan D, Liu L and Gu D: Transcriptional
regulation of livin by beta-catenin/TCF signaling in human lung
cancer cell lines. Mol Cell Biochem. 306:171–178. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yang J, Zhao H, Xin Y and Fan L:
MicroRNA-198 inhibits proliferation and induces apoptosis of lung
cancer cells via targeting FGFR1. J Cell Biochem. 115:987–995.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gigante M, Pontrelli P, Herr W, Gigante M,
D'Avenia M, Zaza G, Cavalcanti E, Accetturo M, Lucarelli G,
Carrieri G, et al: miR-29b and miR-198 overexpression in
CD8+ T cells of renal cell carcinoma patients
down-modulates JAK3 and MCL-1 leading to immune dysfunction. J
Transl Med. 14:842016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang S, Zhao Y and Wang L: MicroRNA-198
inhibited tumorous behaviors of human osteosarcoma through directly
targeting ROCK1. Biochem Biophys Res Commun. 472:557–565. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang M, Wang J, Kong X, Chen H, Wang Y,
Qin M, Lin Y, Chen H, Xu J, Hong J, et al: MiR-198 represses tumor
growth and metastasis in colorectal cancer by targeting fucosyl
transferase 8. Sci Rep. 4:61452014. View Article : Google Scholar : PubMed/NCBI
|
